| scholarly article | Q13442814 |
| P356 | DOI | 10.2174/1389450111009011614 |
| P953 | full work available at URL | http://eurekaselect.com/article/download/72593 |
| P698 | PubMed publication ID | 20735352 |
| P50 | author | Rafael Moreno-Sanchez | Q57574778 |
| Emma Saavedra | Q104904996 | ||
| Viridiana Olín-Sandoval | Q117254345 | ||
| P2093 | author name string | Rafael Moreno-Sánchez | |
| Viridiana Olin-Sandoval | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1614-1630 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Current Drug Targets | Q15724627 |
| P1476 | title | Targeting trypanothione metabolism in trypanosomatid human parasites | |
| Targeting Trypanothione Metabolism in Trypanosomatid Human Parasites | |||
| P478 | volume | 11 |
| Q47414193 | Buthionine sulfoximine is a multitarget inhibitor of trypanothione synthesis in Trypanosoma cruzi |
| Q38786906 | Comparative Metabolism of Free-living Bodo saltans and Parasitic Trypanosomatids |
| Q48051536 | Drug target validation of the trypanothione pathway enzymes through metabolic modelling |
| Q41813592 | Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei. |
| Q50318718 | Functional Characterization of ABCC Proteins from Trypanosoma cruzi and Their Involvement with Thiol Transport. |
| Q92864476 | GDP-Mannose Pyrophosphorylase: A Biologically Validated Target for Drug Development Against Leishmaniasis |
| Q92774155 | Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity |
| Q33766769 | Genetic validation of Trypanosoma brucei glutathione synthetase as an essential enzyme |
| Q34584775 | In silico work flow for scaffold hopping in Leishmania |
| Q90682809 | Overexpression of eukaryotic initiation factor 5A (eIF5A) affects susceptibility to benznidazole in Trypanosoma cruzi populations |
| Q44277644 | Probing the dimerization interface of Leishmania infantum trypanothione reductase with site-directed mutagenesis and short peptides |
| Q27011766 | Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis |
| Q30487641 | Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids |
| Q30359734 | Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors |
| Q38154346 | Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs. |
| Q35752267 | The return of metabolism: biochemistry and physiology of the pentose phosphate pathway |
| Q35855383 | Trypanosomatid comparative genomics: Contributions to the study of parasite biology and different parasitic diseases |
Search more.